This volume of Frontiers in Drug Discovery includes a revision of articles on erythropoiesis and EPO gene regulationmicroRNAs and their potential contribution to the development of new therapeutic strategiesanimal models for studying kidney disease-associated anemia as well as benefits/risks of ESA therapy. The biological effects of new ESA moleculesheparin-binding erythropoietin and of pHBSPand the potential applications of ESAare also elicited in this volume.
This volume isthereforea useful reference for medicinal chemists and hematologists interested in drug development and medicine related to ESAs.
Loading...
Loading...

